Form 8-K - Current report:
SEC Accession No. 0001104659-25-036057
Filing Date
2025-04-17
Accepted
2025-04-17 16:41:15
Documents
16
Period of Report
2025-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512482d1_8k.htm   iXBRL 8-K 31264
2 EXHIBIT 4.1 tm2512482d1_ex4-1.htm EX-4.1 76417
3 EXHIBIT 10.1 tm2512482d1_ex10-1.htm EX-10.1 104754
4 EXHIBIT 10.2 tm2512482d1_ex10-2.htm EX-10.2 100738
  Complete submission text file 0001104659-25-036057.txt   570367

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zura-20250416.xsd EX-101.SCH 3011
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250416_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250416_pre.xml EX-101.PRE 22356
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2512482d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25847909
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)